Health and Human Services Committee

Jenifer Jones / SDPB

A bill standardizing the appeals process for prescription drug coverage is heading to its final hurdle before the governor’s desk.

Senate Bill 155 focuses on step therapy programs and gives patients an appeal option if a new carrier denies coverage of a previously approved drug.

A step therapy program tracks a patient’s reaction to a sequence of drugs in order to find the most effective treatment. It’s often used for rheumatoid arthritis, diabetes, depression and many other conditions.


The Senate Health and Human Services Committee will reconsider a bill that regulates cannabidiol, or CBD, a Schedule IV drug in South Dakota.

That means CBD is available only by prescription.

Opponents to Senate Bill 22 say it criminalizes hemp CBD and prevents the state from exploring hemp as a crop. SDPB's Victoria Wicks has this report.